Indapamide Biogaran (Indapamide)

Indapamide works by blocking the sodium‑chloride transporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of water and electrolytes. The resulting decrease in plasma volume and peripheral vascular resistance lowers blood pressure, while the diuretic effect reduces edema.

The appropriate dose of Indapamide is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and renal function. Dosage may vary, and patients should follow the prescriber’s instructions without altering the regimen on their own.

Safety data for Indapamide during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative treatments with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Indapamide Biogaran. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Indapamide belongs to the thiazide‑like class, offering potent antihypertensive and diuretic effects with a longer half‑life than many traditional thiazides. Compared with loop diuretics, it is less likely to cause severe electrolyte loss but may be less effective for rapid fluid removal. Its profile makes it a common choice for chronic hypertension and mild‑to‑moderate edema.

Indapamide tablets should be stored at room temperature, below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Indapamide is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the prescriber’s guidance regarding timing. Swallow the tablet whole; do not crush or chew unless specifically instructed.

Serious risks include severe electrolyte disturbances such as hyponatremia or hypokalemia, dehydration, and rare blood disorders like agranulocytosis. Patients should be alert for symptoms like extreme weakness, irregular heartbeat, severe dizziness, rash, or swelling of the face and seek medical attention promptly if they occur.

Indapamide is contraindicated in patients with known hypersensitivity to the drug or other thiazide‑like diuretics, severe renal impairment, and those with anuria. Caution is also advised for individuals with uncontrolled diabetes, gout, or a history of electrolyte abnormalities. The prescriber will evaluate suitability before initiating therapy.